SHARE

Applied Nutrition upgrades outlook as revenue and EBITDA outpace forecasts

Applied Nutrition has reported it expects FY26 revenue to rise 50% to £160m and adjusted EBITDA to reach £43.3m. FY27 guidance sits at £205m revenue and £49m EBITDA, both above consensus. US expansion and whey costs are set to impact margins.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.